Event JSON
{
"id": "76c37285ccc0ae314efd92ca041a2d300d28dddc6576805ec635199e3a341fa7",
"pubkey": "de1abdd3127788ab39fb6f558233067d7cf07e8165598738c9a46a9cff3979a0",
"created_at": 1744585619,
"kind": 1,
"tags": [
[
"r",
"https://www.theguardian.com/society/2025/apr/14/melanoma-patients-in-england-get-fast-track-access-to-cancer-vaccine"
],
[
"subject",
"Melanoma patients in England get fast-track access to cancer vaccine"
],
[
"published_at",
"1744585227"
],
[
"image",
"https://i.guim.co.uk/img/media/40335aff708b566272e43ee09d22b8bef85fe0d6/0_160_4832_2901/master/4832.jpg?width=140\u0026quality=85\u0026auto=format\u0026fit=max\u0026s=31eedd78c09edc263a0ca1e0e46c4a41"
],
[
"p",
"de1abdd3127788ab39fb6f558233067d7cf07e8165598738c9a46a9cff3979a0",
"wss://relay-testnet.k8s.layer3.news"
],
[
"p",
"9d3345095e986ded9af724d26a8c5bee050bfd615c32fc5e76981a089c72008e",
"wss://relay-testnet.k8s.layer3.news"
],
[
"imeta",
"url https://i.guim.co.uk/img/media/40335aff708b566272e43ee09d22b8bef85fe0d6/0_160_4832_2901/master/4832.jpg?width=140\u0026quality=85\u0026auto=format\u0026fit=max\u0026s=31eedd78c09edc263a0ca1e0e46c4a41"
],
[
"t",
"Prof Peter Johnson"
],
[
"t",
"Keir Starmer"
],
[
"t",
"Susanna Daniels"
],
[
"t",
"England"
],
[
"t",
"UK"
],
[
"t",
"health"
],
[
"t",
"liberal:perspective"
],
[
"summary",
"The vaccine, developed by Scancell, is part of the NHS England's Cancer Vaccine Launch Pad program, which aims to provide 10,000 patients with personalized cancer treatments by 2030. The trial will be conducted at seven hospitals across the country, and patients with advanced skin melanoma will be given fast-track access. The vaccine has the potential to revolutionize cancer care and save lives."
]
],
"content": "nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgyaxdzsjh5cdhke4aey6f4gcklwq59l6c2uxt79ua5crgyfcusq3cwyf5fq\nMELANOMA PATIENTS IN ENGLAND GET FAST-TRACK ACCESS TO CANCER VACCINE\n\nhttps://i.guim.co.uk/img/media/40335aff708b566272e43ee09d22b8bef85fe0d6/0_160_4832_2901/master/4832.jpg?width=140\u0026quality=85\u0026auto=format\u0026fit=max\u0026s=31eedd78c09edc263a0ca1e0e46c4a41\n--\n✍️ The NHS in England is launching a trial for a new cancer vaccine, iSCIB1+, which helps the immune system recognize cancer cells and respond to immunotherapy treatment.\n--\n👉 The NHS is launching a trial for a new cancer vaccine, iSCIB1+, in England\n👉 The vaccine helps the immune system recognize cancer cells and respond to immunotherapy treatment\n👉 The trial is part of the NHS England's Cancer Vaccine Launch Pad program\n👉 The program aims to provide 10,000 patients with personalized cancer treatments by 2030\n👉 Patients with advanced skin melanoma will be given fast-track access to the trial\n\n--\n#ProfPeterJohnson #KeirStarmer #SusannaDaniels #England #UK #health\n--\nnostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqg8n23ft5tc6rw8wsxta8aj8fgwls7w36xp8uju8fyxe8envv5zzl5knhqzv \n ",
"sig": "ee71882821db07451840b062306cfe78e3df61270bcfed9da4c1bccf98d3ee4696484952bd34f632d5cb8874c68fd14f6c826744f6bcb802c9ca6e7bac8cf3f0"
}
